Suppr超能文献

BATF 抑制 BIM 以维持外周耐受 T 细胞。

BATF represses BIM to sustain tolerant T cells in the periphery.

机构信息

Department of Medicine, Center for Immunology, University of Minnesota Medical School, Minneapolis, MN, USA.

出版信息

J Exp Med. 2023 Dec 4;220(12). doi: 10.1084/jem.20230183. Epub 2023 Oct 20.

Abstract

T cells that encounter self-antigens after exiting the thymus avert autoimmunity through peripheral tolerance. Pathways for this include an unresponsive state known as anergy, clonal deletion, and T regulatory (Treg) cell induction. The transcription factor cues and kinetics that guide distinct peripheral tolerance outcomes remain unclear. Here, we found that anergic T cells are epigenetically primed for regulation by the non-classical AP-1 family member BATF. Tolerized BATF-deficient CD4+ T cells were resistant to anergy induction and instead underwent clonal deletion due to proapoptotic BIM (Bcl2l11) upregulation. During prolonged antigen exposure, BIM derepression resulted in fewer PD-1+ conventional T cells as well as loss of peripherally induced FOXP3+ Treg cells. Simultaneous Batf and Bcl2l11 knockdown meanwhile restored anergic T cell survival and Treg cell maintenance. The data identify the AP-1 nuclear factor BATF as a dominant driver of sustained T cell anergy and illustrate a mechanism for divergent peripheral tolerance fates.

摘要

离开胸腺后遇到自身抗原的 T 细胞通过外周耐受避免自身免疫。实现这一目标的途径包括一种称为无能的无反应状态、克隆删除和 T 调节(Treg)细胞诱导。指导不同外周耐受结果的转录因子线索和动力学仍然不清楚。在这里,我们发现无能的 T 细胞在表观遗传上被预先设定为受非经典 AP-1 家族成员 BATF 的调节。耐受的 BATF 缺陷型 CD4+T 细胞对无能诱导具有抗性,而是由于促凋亡的 BIM(Bcl2l11)上调而发生克隆删除。在长时间的抗原暴露下,BIM 的去抑制导致 PD-1+常规 T 细胞减少以及外周诱导的 FOXP3+Treg 细胞丢失。同时敲低 Batf 和 Bcl2l11 同时恢复了无能 T 细胞的存活和 Treg 细胞的维持。数据表明 AP-1 核因子 BATF 是持续 T 细胞无能的主要驱动因素,并说明了不同外周耐受命运的一种机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89a4/10588758/de3d3eca2422/JEM_20230183_Fig1.jpg

相似文献

1
BATF represses BIM to sustain tolerant T cells in the periphery.
J Exp Med. 2023 Dec 4;220(12). doi: 10.1084/jem.20230183. Epub 2023 Oct 20.
2
Nur77 Regulates Nondeletional Mechanisms of Tolerance in T Cells.
J Immunol. 2017 Nov 1;199(9):3147-3157. doi: 10.4049/jimmunol.1701085. Epub 2017 Sep 25.
4
Self and microbiota-derived epitopes induce CD4 T cell anergy and conversion into CD4Foxp3 regulatory cells.
Mucosal Immunol. 2021 Mar;14(2):443-454. doi: 10.1038/s41385-020-00349-4. Epub 2020 Nov 2.
5
Defects in the Bcl-2-regulated apoptotic pathway lead to preferential increase of CD25 low Foxp3+ anergic CD4+ T cells.
J Immunol. 2011 Aug 15;187(4):1566-77. doi: 10.4049/jimmunol.1100027. Epub 2011 Jul 8.
6
Loss of the proapoptotic protein, Bim, breaks B cell anergy.
J Exp Med. 2006 Mar 20;203(3):731-41. doi: 10.1084/jem.20051407. Epub 2006 Mar 6.
7
Self-antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion.
Blood. 2011 Jul 28;118(4):984-91. doi: 10.1182/blood-2011-02-336115. Epub 2011 Jun 7.
8
Proapoptotic protein Bim is differentially required during thymic clonal deletion to ubiquitous versus tissue-restricted antigens.
Proc Natl Acad Sci U S A. 2012 Jan 17;109(3):893-8. doi: 10.1073/pnas.1114834109. Epub 2012 Jan 3.
9
Opposing peripheral fates of tissue-restricted self antigen-specific conventional and regulatory CD4 T cells.
Eur J Immunol. 2020 Jan;50(1):63-72. doi: 10.1002/eji.201948180. Epub 2019 Oct 14.
10
Anergy in peripheral memory CD4(+) T cells induced by low avidity engagement of T cell receptor.
J Exp Med. 2001 Sep 17;194(6):719-31. doi: 10.1084/jem.194.6.719.

引用本文的文献

1
Cell-intrinsic CD4 T cell tolerance: a new frontier in therapy?
Trends Immunol. 2025 Jul 23. doi: 10.1016/j.it.2025.07.001.
2
The mechanisms and clinical significance of CD8 T cell exhaustion in anti-tumor immunity.
Cancer Biol Med. 2025 Jun 10;22(5). doi: 10.20892/j.issn.2095-3941.2024.0628.
3
Vps34-orchestrated lipid signaling processes regulate the transitional heterogeneity and functional adaptation of effector regulatory T cells.
PLoS Biol. 2025 Apr 11;23(4):e3003074. doi: 10.1371/journal.pbio.3003074. eCollection 2025 Apr.
4
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy.
Signal Transduct Target Ther. 2025 Mar 21;10(1):91. doi: 10.1038/s41392-025-02176-0.
5
The role of BATF in immune cell differentiation and autoimmune diseases.
Biomark Res. 2025 Jan 29;13(1):22. doi: 10.1186/s40364-025-00733-x.
6
Knockdown of BATF alleviates lung injury in septic neonates through transcriptional regulation of COTL1.
Cent Eur J Immunol. 2024;49(3):238-251. doi: 10.5114/ceji.2024.144865. Epub 2024 Nov 18.
7
JunB is required for CD8+ T cell responses to acute infections.
Int Immunol. 2025 Mar 6;37(4):203-220. doi: 10.1093/intimm/dxae063.

本文引用的文献

1
JunB Is Critical for Survival of T Helper Cells.
Front Immunol. 2022 Jun 28;13:901030. doi: 10.3389/fimmu.2022.901030. eCollection 2022.
2
Batf-mediated epigenetic control of effector CD8 T cell differentiation.
Sci Immunol. 2022 Feb 18;7(68):eabi4919. doi: 10.1126/sciimmunol.abi4919.
3
BATF and IRF4 cooperate to counter exhaustion in tumor-infiltrating CAR T cells.
Nat Immunol. 2021 Aug;22(8):983-995. doi: 10.1038/s41590-021-00964-8. Epub 2021 Jul 19.
4
BATF regulates progenitor to cytolytic effector CD8 T cell transition during chronic viral infection.
Nat Immunol. 2021 Aug;22(8):996-1007. doi: 10.1038/s41590-021-00965-7. Epub 2021 Jul 19.
5
Harnessing the IL-21-BATF Pathway in the CD8 T Cell Anti-Tumor Response.
Cancers (Basel). 2021 Mar 12;13(6):1263. doi: 10.3390/cancers13061263.
6
Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells.
Immunity. 2021 Apr 13;54(4):702-720.e17. doi: 10.1016/j.immuni.2021.03.007. Epub 2021 Mar 30.
7
Dynamic adoption of anergy by antigen-exhausted CD4 T cells.
Cell Rep. 2021 Feb 9;34(6):108748. doi: 10.1016/j.celrep.2021.108748.
8
The transcription factor IRF4 represses proapoptotic BMF and BIM to licence multiple myeloma survival.
Leukemia. 2021 Jul;35(7):2114-2118. doi: 10.1038/s41375-020-01078-0. Epub 2020 Nov 4.
9
Self and microbiota-derived epitopes induce CD4 T cell anergy and conversion into CD4Foxp3 regulatory cells.
Mucosal Immunol. 2021 Mar;14(2):443-454. doi: 10.1038/s41385-020-00349-4. Epub 2020 Nov 2.
10
Rethinking peripheral T cell tolerance: checkpoints across a T cell's journey.
Nat Rev Immunol. 2021 Apr;21(4):257-267. doi: 10.1038/s41577-020-00454-2. Epub 2020 Oct 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验